Corrona was founded in 2001 by leading rheumatologists dedicated to advancing and improving the care of patients with autoimmune diseases.

Corrona's Mission is to advance medical research and improve patient care by providing unique, proprietary data on treatment efficacy and outcomes of patients with autoimmune diseases in a real-world setting.

About Corrona

Corrona is a real world evidence business providing registry data and consulting services to biopharmaceutical companies. Our clients face major challenges to demonstrate the health outcomes of their drugs. This may be achieved through legislative and regulatory-mandated pathways (e.g., post-approval surveillance requirements, REMS programs, pharmacovigilance plans), by analyzing comparative effectiveness data to generate potential new claims, or measuring health outcomes to justify the value of the drug to payers.

The Corrona model for data collection involves developing and sustaining a robust network of affiliate clinical sites, both academic and private, which contribute data from both physicians and patients. The sites are compensated for their data collection and submission efforts. All research programs are conducted under the oversight of a contracted Institutional Review Board or other local authority (e.g., an academic site). The data that are collected from the sites undergoes quality control for accuracy and completeness, and is stored in a secure data warehouse for access by Corrona biostatisticians and epidemiologists.

Corrona is an independent registry without any ownership links to the pharmaceutical industry.

Corrona Leadership Team

The leadership team of Corrona is dedicated to the delivery of world class scientific data. The professionals represent research, clinical, legal, analytical, business and quality domains.

  • Jessica Eisenhaure

    Jessica Eisenhaure

    SVP & General Counsel
  • Carol J. Etzel, PhD

    Chief Statistical Officer
  • Jeffrey Greenberg, MD, MPH

    Jeffrey Greenberg, MD, MPH

    Chief Medical Officer
  • Leslie R. Harrold, MD, MPH

    Chief Scientific Officer
  • Raymond Hill

    Raymond Hill

    CEO and Chairman of the Board
  • DB Kartik

    DB Kartik

    President & Chief Operating Officer
  • Austin Read

    Austin Read

    VP of Finance

Scientific Advisors

The central function of the advisors is to provide scientific advice on a wide variety of matters concerning scientific program policy, progress and future direction of Corrona’s extramural research programs. The advisory group brings together in a coherent manner the collective capacity of all relevant scientific fields, with due regard to the autoimmune diseases spectrum. The Scientific Advisors are entrusted with the following:

  • strengthening the linkage between science and policy
  • ensuring that up-to-date and rigorous science is appropriately reflected
  • offering recommendations to ensure Corrona is carrying out intellectual work on up-to-date scientific issues
  • offering consultation on science and technology that will encourage sustainable development
  • Raymond K. Cross, Jr., M.D., M.S., AGAF, FACG

    Raymond K. Cross, Jr., M.D., M.S., AGAF, FACG

    University of Maryland, Baltimore
  • Daniel J. Kantor, M.D., FAAN, FANA

    Daniel J. Kantor, M.D., FAAN, FANA

    Florida Atlantic University
  • Joshua R. Korzenik, M.D.

    Joshua R. Korzenik, M.D.

    Brigham and Women’s Hospital
  • Joel Kremer, MD

    Joel Kremer, MD

  • Mark G. Lebwohl, M.D.

    Mark G. Lebwohl, M.D.

    Icahn School of Medicine at Mount Sinai
  • Philip J. Mease, M.D.

    Philip J. Mease, M.D.

    University of Washington
  • Aaron E. Miller, M.D., FAAN

    Aaron E. Miller, M.D., FAAN

    Icahn School of Medicine at Mount Sinai
  • Bruce E. Strober, M.D., Ph.D.

    Bruce E. Strober, M.D., Ph.D.

    University of Connecticut
  • Hisashi Yamanaka, M.D., Ph.D.

    Hisashi Yamanaka, M.D., Ph.D.

    Tokyo Women’s Medical University